Clinical Trials Logo

Filter by:
NCT ID: NCT02250547 Completed - CRT Patients Clinical Trials

Optimization With SonR Method in the ClinicAl pRactice

OSCAR
Start date: July 2012
Phase: N/A
Study type: Observational

Evaluate the percentage of patients optimized at least once every month by the SonR automatic optimization method, until M6 follow-up, in Heart failure (HF) patients prevalently in sinus rhythm

NCT ID: NCT02250326 Completed - Clinical trials for Carcinoma, Non-Small-Cell Lung

Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 or Nab®-Paclitaxel With Durvalumab, and Nab®-Paclitaxel Monotherapy as Second/Third-line Treatment for Advanced Non-small Cell Lung Cancer

abound2L+
Start date: January 7, 2015
Phase: Phase 2
Study type: Interventional

This is a Phase 2, open-label, multicenter study to assess the efficacy and safety of second/third-line treatment with nab-paclitaxel in combination with the epigenetic modifying therapy of CC-486 or immunotherapy of durvalumab, and nab-paclitaxel monotherapy in subjects with advanced non-small cell lung cancer (NSCLC).

NCT ID: NCT02250040 Completed - Stroke Clinical Trials

Effect of a Physiotherapy Protocol for Gait and Functional Recovery After Stroke

Start date: March 2011
Phase: N/A
Study type: Interventional

The purpose of this study was to identify and evaluate the effect of a new protocol of physiotherapy to retrain walking ability after stroke in subjects older than fifty-five. This protocol was composed of specific, clearly defined and reproducible techniques, based on clinical and functional criteria.

NCT ID: NCT02248948 Completed - Clinical trials for Attention Deficit Hyperactivity Disorder (ADHD)

Superiority of Omega-3 Versus Placebo on the Improvement of ADHD in Children

ECOMEGA
Start date: September 2014
Phase: N/A
Study type: Interventional

This study aims to evaluate the efficacy of an Omega-3 Fatty Acid Supplement on improving the Attention Deficit Hyperactivity Disorder (ADHD) clinical symptoms.

NCT ID: NCT02248766 Completed - Astigmatism Clinical Trials

Clinical Performance of Habitual Wearers of Avaira Toric When Refitted With Clariti Toric Lenses

Start date: September 2014
Phase: N/A
Study type: Interventional

The aim of this dispensing study is to evaluate the clinical performance of existing wearers of Avaira toric lenses following a refit with Clariti toric over 1 month of daily wear.

NCT ID: NCT02248727 Completed - Myopia Clinical Trials

Clinical Performance of Existing Wearers of Avaira Sphere Following a Refit With Clariti Elite Sphere

Start date: September 2014
Phase: N/A
Study type: Interventional

The aim of this dispensing study is to evaluate the clinical performance of existing wearers of Avaira sphere lenses following a refit with Clariti Elite sphere over 4 weeks of daily wear.

NCT ID: NCT02248506 Completed - Clinical trials for Candidiasis, Vulvovaginal

Epidemiological Study About the Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis

Start date: June 2013
Phase: Phase 4
Study type: Interventional

To determine proportion of women achieving clinical and mycological cure or have recurrences / reinfection after being treated for an acute episode of vulvovaginal candidiasis.

NCT ID: NCT02247804 Completed - Ocular Hypertension Clinical Trials

Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension

Start date: December 15, 2014
Phase: Phase 3
Study type: Interventional

This study will evaluate the efficacy and safety of bimatoprost SR in participants with open-angle glaucoma or ocular hypertension. The study includes a 12-month treatment period with an 8-month extended follow-up.

NCT ID: NCT02247310 Completed - Clinical trials for Multiple Sclerosis, Relapsing Remitting

BETAEVAL Global - The New BETACONNECT Auto-injector : Adherence and EVALuation of Multiple Sclerosis Patients Treated With Betaferon

Start date: October 20, 2014
Phase: N/A
Study type: Observational

Considering the significance of an early and consequent Multiple Sclerosis (MS) treatment as well as the challenge to achieve high adherence to treatment, evaluating the benefits of any new measure to improve adherence is important. The data storage capabilities of the BETACONNECT device, including the automated recording of injections, will facilitate the collection of reliable data on patient's injection behavior and adherence, which should be unaffected by recall bias or reporting bias. To better understand the utilities of the new BETACONNECT device and characterize its contribution to adherence, we plan to prospectively follow-up MS patients using this device for 24 weeks. The study will take place in a real-life setting in Neurology centers across Europe.

NCT ID: NCT02246998 Completed - HIV-1 Infection Clinical Trials

Renal Effect of Stribild or Other Tenofovir DF-containing Regimens Compared to Ritonavir-boosted Atazanavir Plus Abacavir/Lamivudine in Antiretroviral Treatment-naive HIV-1 Infected Adults

Start date: December 15, 2014
Phase: Phase 4
Study type: Interventional

The primary objective of this study is to assess glomerular function before and during administration of stribild (STB; elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate (E/C/F/TDF)) or a regimen containing TDF without cobicistat (COBI) as ritonavir (RTV)-boosted atazanavir (ATV/r) plus truvada (TVD; FTC/TDF) or atripla (ATR; efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF)) compared to a regimen containing neither TDF nor COBI as ATV/r plus abacavir/lamivudine (ABC/3TC) via determination of actual glomerular filtration rate (aGFR) using iohexol (a probe GFR marker) plasma clearance and estimated (calculated) glomerular filtration rate (eGFR).